¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"minimal change nephropathy"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
¿µ¹® diabetic nephropathy ÇÑ±Û ´ç´¢º´ÄáÆÏº´Áõ
¼³¸í   
  ¿À·¡µÈ ´ç´¢ÀÇ ÇÕº´ÁõÀ¸·Î ¹ß»ýÇÑ´Ù. ´ë°³ ´ç´¢º´¿¡ ÀÌȯµÈ °æ¿ì ´ç´¢º´ ÀÚü¿¡ ÀÇÇÑ Áúº´º¸´Ù ¿À·£ ±â°£ÈÄÀÇ ÇÕº´Áõ¿¡ ÀÇÇØ ¸ñ¼ûÀ» ÀҴ °æ¿ì°¡ ¸¹´Ù. Ãʱ⿡ ´ç´¢º´¿¡¼­ Ç÷Áß Æ÷µµ´ç³óµµ¸¦ Àß Á¶ÀýÇÑ °æ¿ì ÀÌ·± ÇÕº´ÁõÀÌ ¹ß»ýÇϴ °æ¿ì°¡ ³·À¸³ª, ±×·¸Áö ¸øÇÑ °æ¿ì ½ÅÀåÀÇ ÇÕº´ÁõÀÌ ¹ß»ýÇÒ ¼ö ÀÖ´Ù. Çѹø ¹ß»ýÇÑ °æ¿ì, Ä¡·á´Â ºÒ°¡´ÉÇϸç, ±× ÁøÇà ¶ÇÇÑ ´ÊÃâ ¼ö ¾ø´Ù. Ä¡·á¹ýÀº ¿ÀÁ÷ Çϳª ÄáÆÏÀ̽ļú¿¡ ÀÇÇØ¼­¸¸ °¡´ÉÇϸç À̽ļúÀ» ½ÃÇàÇÑ ÀÌÈÄ¿¡µµ Ç÷´ç·®ÀÇ Á¶ÀýÀº ÇʼöÀûÀÌ´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • minimal change disease
    ¹Ì¼¼º¯È­º´
  • change
    º¯È­
  • exothermic change
    ¹ß¿­º¯È­
  • fatty change
    Áö¹æº¯È­
  • irreversible change
    ºñ°¡¿ªº¯È­
  • malignant change
    ¾Ç¼ºº¯È­
  • reversible change
    °¡¿ªº¯È­
  • analgesic nephropathy
    ÁøÅëÁ¦ÄáÆÏº´(Áõ), ÁøÅëÁ¦½ÅÀ庴(Áõ)
  • diabetic nephropathy
    ´ç´¢ÄáÆÏº´(Áõ), ´ç´¢½ÅÀ庴(Áõ)
  • gouty nephropathy
    ÅëdzÄáÆÏº´(Áõ), Åëdz½ÅÀ庴(Áõ)
  • hyperuricemic nephropathy
    °í¿ä»êÇ÷ÁõÄáÆÏº´(Áõ), °í¿ä»êÇ÷Áõ½ÅÀ庴(Áõ)
  • IgA nephropathy
    IgAÄáÆÏº´(Áõ), IgA½ÅÀ庴(Áõ)
  • light-chain nephropathy
    °¡º­¿î»ç½½ÄáÆÏº´(Áõ), °æ¼â½ÅÀ庴(Áõ)
  • membranous nephropathy
    ¸·¼ºÄáÆÏº´(Áõ), ¸·¼º½ÅÀ庴(Áõ)
  • nephropathy
    ÄáÆÏº´(Áõ), ½ÅÀ庴(Áõ)
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 7 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • minimal invasive surgery
    ÃÖ¼Òħ½À¼ö¼ú
  • nephropathy
    ÄáÆÏº´Áõ, ½ÅÀ庴Áõ
  • IgA nephropathy
    ¸é¿ª±Û·Îºí¸°¿¡ÀÌÄáÆÏº´Áõ, ¸é¿ª±Û·Îºí¸°¿¡À̽ÅÀ庴Áõ
  • diabetic nephropathy
    ´ç´¢º´ÄáÆÏº´Áõ
  • membranous nephropathy
    ¸·¼ºÄáÆÏº´Áõ
  • urate nephropathy
    ¿ä»ê¿°ÄáÆÏº´Áõ
  • uric acid nephropathy
    (¢¡ urate nephropathy) ¿ä»ê¿°ÄáÆÏº´Áõ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • minimal change disease
    ÃÖ¼Òº¯È­ÄáÆÏº´Áõ
  • change
    º¯È­
  • exothermic change
    ¹ß¿­º¯È­
  • fatty change
    Áö¹æº¯¼º
  • irreversible change
    ºñ°¡¿ªº¯È­
  • malignant change
    ¾Ç¼ºº¯È­
  • reversible change
    °¡¿ªº¯È­
  • time zone change syndrome
    (¢¡jet lag syndrome) ºñÇà½ÃÂ÷ÁõÈıº
  • analgesic nephropathy
    ÁøÅëÁ¦ÄáÆÏº´Áõ
  • diabetic nephropathy
    ´ç´¢º´ÄáÆÏº´Áõ
  • gouty nephropathy
    ÅëdzÄáÆÏº´Áõ
  • hyperuricemic nephropathy
    °í´¢»êÇ÷ÁõÄáÆÏº´Áõ
  • light-chain nephropathy
    °¡º­¿î»ç½½ÄáÆÏº´Áõ
  • membranous nephropathy
    (¢¡glomerulonephritis) Å丮ÄáÆÏ¿°, »ç±¸Ã¼½Å¿°
  • nephropathy
    ÄáÆÏº´Áõ, ½ÅÀ庴Áõ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Kobraks minimal stimulation
    ÄÚºê¶ô¾àÀڱعý
  • Balkan nephropathy
    ¹ßÄ­ ½Åº´Áõ
  • analgesic nephropathy
    ÁøÅëÁ¦Àμº ½Åº´Áõ
  • gouty nephropathy
    Åëdz¼º ½Åº´Áõ
  • hyperuricemic nephropathy
    °í¿ä»êÇ÷Áõ¼º ½Åº´Áõ.
  • hyperuricemic nephropathy
    °í´¢»êÇ÷Áõ¼º ½Åº´Áõ.
  • immunoglobulin a nephropathy
    ¸é¿ª±Û·ÎºÒ¸°A½Åº´Áõ(Øó湡­ãìÜ»ñø)
  • Climactic change
    °»³â±â¼º º¯È­
  • frequency change
    Á֯ļö º¯È­
  • genotypic change
    À¯ÀüÀÚÇüº¯ÀÌ.
  • hypertensive change
    °íÇ÷¾Ð¼º º¯È­ ¾ÈÀú(äÑî¼)ÀÇ .
  • phasic change
    À§»ó¼º º¯È­(êÈßÓàõܨûù).
  • physical change
    ¹°¸®º¯È­(ÚªìµÜ¨ûù).
  • rachitic change
    ±¸·ç¼º º¯È­( ×§àõܨûù).
  • rachitic change
    ±¸·ç¼º º¯È­(±¸×§àõܨûù)
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • minimal change disease
    ¹Ì¼Òº¯È­ »ç±¸Ã¼½Å¿°
  • minimal change disease
    ¹Ì¼Ò º´º¯½ÅÁõ(ڰܻ᳠ܨãìñø)
  • analgesic nephropathy
    ÁøÅëÁ¦Àμº ½Åº´Áõ
  • balkan nephropathy
    ¹ßÄ­ ½ÅÁõ(¡­ãìñø)
  • diabetic nephropathy
    ´ç´¢º´(¼º) ½Åº´Áõ.
  • diabetic nephropathy
    ´ç´¢º´¼º ½Åº´Áõ(¡­ãìÜ»ñø)
  • gouty nephropathy
    Åëdz¼º ½Åº´Áõ
  • hyperuricemic nephropathy
    °í¿ä»êÇ÷Áõ¼º ½Åº´Áõ.
  • hyperuricemic nephropathy
    °í´¢»êÇ÷Áõ¼º ½Åº´Áõ.
  • hypokalemic nephropathy
    ÀúÄ®·ý¼º ½Åº´Áõ.
  • hypokalemic nephropathy
    ÀúÄ®·ýÇ÷¼º ½Åº´Áõ
  • immunoglobulin a nephropathy
    ¸é¿ª±Û·ÎºÒ¸°A½Åº´Áõ(Øó湡­ãìÜ»ñø)
  • light-chain nephropathy
    °æ¼â ½ÅÁõ(Ìã ãìñø)
  • membranous nephropathy
    ¸·¼º½Åº´Áõ(¡­ãìÜ»ñø)
  • nephropathy
    ½Åº´Áõ,(¡­Ü»ñø), ½ÅÁõ(¡­ñø)
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 8 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • minimal medium
    ÃÖ¼Ò¹èÁö(õÌá³ÛÆò¢)
  • minimal stable length
    ÃÖ¼Ò¾ÈÁ¤(õÌá³äÌïÒ) ±æÀÌ
  • enthalpy change
    ¿£Å»ÇÇ º¯È­(ܨûù)
  • entropy change
    ¿£Æ®·ÎÇÇ º¯È­(ܨûù)
  • free energy change
    ÀÚÀ¯(í»ë¦) ¿¡³ÊÁö º¯È­(ܨûù)
  • standard enthalpy change
    Ç¥ÁØ(øöñÞ) ¿£Å»ÇÇ º¯È­(ܨûù)
  • standard entropy change
    Ç¥ÁØ(øöñÞ) ¿£Æ®·ÎÇÇ º¯È­(ܨûù)
  • standard free energy change
    Ç¥ÁØ(øöñÞ) ÀÚÀ¯(í»ë¦)¿¡³ÊÁö º¯È­(ܨûù)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 8 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • nephropathy
    ½Åº´Áõ, ½ÅÁõ
  • minimal
    ÃÖ¼ÒÀÇ
  • minimal effective dose
    ÃÖ¼ÒÀ¯È¿·®
  • minimal enhancement
    ¹Ì¹ÌÇÑÁ¶¿µÁõ°­, °æµµÀÇÁ¶¿µÁõ°­
  • change
    º¯È­, º¯Á¶
  • frequency change
    Á֯ļöº¯È­
  • malignant change
    ¾Ç¼ºº¯È­
  • reversible change
    °¡¿ªº¯È­
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
MCN maternal child nursing; minimal change nephropathy; mixed cell nodular [lymphoma]
MCD magnetic circular dichroism; mast-cell degranulation; mean cell diameter; mean of consecutive differ...
MRD maximum rate of depolarization; measles-rindenpest-distemper [virus group]; medical records departme...
AAN AIDS-associated nephropathy; alpha-amino nitrogen; American Academy of Neurology; American Academy o...
KW change Keith Wagener change
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
MCN Minimal change nephropathy
MCD Minimal change disease
MCNS Minimal change nephrotic syndrome
CGI-C Clinical Global Impression of Change
FAC Fractional area change
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • analgesic nephropathy
    ÁøÅëÁ¦Àμº ½Åº´Áõ
  • balkan nephropathy
    ¹ßÄ­ ½ÅÁõ
  • nephropathy
    ½Åº´Áõ, ½ÅÁõ, ½ÅÀ庴Áõ
    ½ÅÀå¿¡ »ý±ä Áúº´.
  • obstructive nephropathy
    Æó¼â¼º ½Å Áúȯ
  • Eagle`s minimal essential medium
    ÀÌ±Û ¹èÁö
    ¼¼Æ÷ ¹è¾ç¾×ÀÇ ÀÏÁ¾. 3Á¾·ùÀÇ ¾Æ¹Ì³ë»ê°ú 8Á¾·ùÀÇ ºñŸ¹ÎÀ» ÇÔÀ¯Çϰí ÀÖÀ¸¸ç º¸Åë Ç÷û 5% ÀÌÇÏ¿¡¼­ À¯Áö ¹èÁö·Î¼­ »ç¿ëµÇ°í 10-20%ÀÇ Ç÷û ÷°¡·Î ¸¹Àº ¼¼Æ÷´Â ±ØÈ÷ ¾çÈ£ÇÑ ¹ßÀ°À» ³ªÅ¸³½´Ù.
  • minimal
    ÃÖ¼ÒÀÇ
    °¡Àå °¡´É¼ºÀÌ ÀûÀº.
  • minimal dose
    ÃÖ¼Ò·®
  • minimal enhancement
    ¹Ì¹ÌÇÑ Á¶¿µ Áõ°­, °æµµÀÇ Á¶¿µ Áõ°­
  • minimal identifiable odor
    ÃÖ¼Ò ºÐÇØ Ãë°¢
  • minimal requirement
    ÃÖ¼Ò ±Ô°Ý
  • minimal temperature
    ÃÖÀú ¿Âµµ
  • black change
    Èæ»ö º¯È­
  • blue-black change
    Ã»Èæ º¯È­
  • brown change
    °¥»ö º¯È­
  • brownish change
    °¥»ö º¯È­
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
minimal-change disease <nephrology> A disorder of the kidneys which largely affects the glomerulus, the blood filtering structure.
This disorder is one common cause of nephrotic syndrome, minimal glomerular changes, in children affecting 2 to 3 children per 100,000 population under age 16 in the USA. Minimal change disease is also seen rarely in adults. The cause is unknown but may be related to an autoimmune illness.
It is marked by oedema, albuminuria, and an increase in cholesterol in the blood, but otherwise with fairly good renal function. Tubular epithelium is vacuolated by cholesterol droplets, but the glomeruli show only that the foot processes of the glomerular epithelial cells are fused, probably secondary to the proteinuria; the cause of the increased glomerular permeability to plasma protein is unknown.
Risk factors include a history for a immune disorder, recent immunisation or a bee sting.
Diagnosis is made by renal biopsy.
Treatment include systemic corticosteroids which are usually quite effective in curing this disease. Other medications include chlorambucil and cyclophosphamide. In most cases, a moderate protein diet (1 gram protein per Kg body weight per day) will be recommended. Salt (sodium) restriction can be helpful to reduce swelling and vitamin D is usually supplemented.
Synonym: lipoid nephrosis
(27 Sep 1997)
minimal-change nephrotic syndrome <nephrology> A disorder of the kidneys which largely affects the glomerulus, the blood filtering structure.
This disorder is one common cause of nephrotic syndrome, minimal glomerular changes, in children affecting 2 to 3 children per 100,000 population under age 16 in the USA. Minimal change disease is also seen rarely in adults. The cause is unknown but may be related to an autoimmune illness.
It is marked by oedema, albuminuria, and an increase in cholesterol in the blood, but otherwise with fairly good renal function. Tubular epithelium is vacuolated by cholesterol droplets, but the glomeruli show only that the foot processes of the glomerular epithelial cells are fused, probably secondary to the proteinuria; the cause of the increased glomerular permeability to plasma protein is unknown.
Risk factors include a history for a immune disorder, recent immunisation or a bee sting.
Diagnosis is made by renal biopsy.
Treatment include systemic corticosteroids which are usually quite effective in curing this disease. Other medications include chlorambucil and cyclophosphamide. In most cases, a moderate protein diet (1 gram protein per Kg body weight per day) will be recommended. Salt (sodium) restriction can be helpful to reduce swelling and vitamin D is usually supplemented.
Synonym: lipoid nephrosis
(27 Sep 1997)
aids-associated nephropathy Renal syndrome in human immunodeficiency virus-infected patients characterised by nephrotic syndrome, severe proteinuria, focal and segmental glomerulosclerosis with distinctive tubular and interstitial changes, enlarged kidneys, and peculiar tubuloreticular structures. The syndrome is distinct from heroin-associated nephropathy as well as other forms of kidney disease seen in HIV-infected patients.
(12 Dec 1998)
analgesic nephropathy <nephrology, pathology> A form of kidney damage which can occur from the overexposure to certain analgesics (for example acetaminophen, salicylates and non-steroidal anti-inflammatory agents).
In most cases analgesic use is excessive in dosing or chronicity of use. Complications include acute renal failure.
See: interstitial nephritis.
Origin: Gr. Pathos = disease
(27 Sep 1997)
balkan nephropathy A tubulointerstitial disease of unknown aetiology occurring in a limited geographic area including adjacent regions of romania, bulgaria, and yugoslavia.
(12 Dec 1998)
reflux nephropathy <nephrology> A condition where the chronic backup of urine into a kidney results in kidney damage. Urine is forced out of the bladder and back toward kidney. This condition occurs most commonly in children who have congenital abnormalities of the urinary tract.
Symptoms include back pain, flank, pain, abdominal pain, urinary frequency or urgency and blood in the urine. Other symptoms include nausea, fever and chills, most often indicating a kidney infection has occurred.
Diagnosis is frequently confirmed by voiding cystourethrogram. Surgery is often required to correct the reflux of urine.
Origin: Gr. Pathos = disease
(27 Sep 1997)
membranous nephropathy <pathology> A kidney disease that occurs due to inflammation of the kidney glomerulus and its basement membrane.
The exact cause is unknown but it appears to be related to the deposition of immune complexes in the basement membrane leading to thickening of the capillary walls. This disorder is a common cause of nephrotic syndrome an is usually how the disease manifests.
Risk factors include primary renal disease, malaria, hepatitis B, lupus, syphilis, cancers and non-Hodgkin's lymphomas. Risks also include exposure to some medications such as gold compounds and penicillamine. Mercury, trimethadione and some skin-lightening creams have also been implicated.
Treatment includes systemic corticosteroids and immunosuppressive agents.
(26 Mar 1998)
hereditary deafness and nephropathy <nephrology, pathology> An inherited disorder involving damage to the kidneys, haematuria and hearing loss. In some individuals vision may also be affected. This genetic disease is uncommon.
Symptoms include loss of hearing, abnormal colour to urine, swelling, cough and decline in vision.
Inheritance: sex-linked autosomal dominant.
Incidence: 1 in 50,000.
Origin: Gr. Pathos = disease
(27 Sep 1997)
hypokalaemic nephropathy Vacuolation of the epithelial cytoplasm of renal convoluted tubules in patients seriously depleted of potassium; vacuoles do not contain fat or glycogen, concentrating ability is impaired, polyuria and polydipsia are common, and pyelonephritis may develop.
Synonym: vacuolar nephrosis.
(05 Mar 2000)
nephropathy <nephrology, urology> Any disease of the kidneys.
Origin: Gr. Pathos = disease
(18 Nov 1997)
Danubian endemic familial nephropathy A tubulointerstitial disease of unknown aetiology occurring in a limited geographic area including adjacent regions of romania, bulgaria, and yugoslavia.
(12 Dec 1998)
diabetic nephropathy <nephrology, pathology> Kidney disease and resultant kidney function impairment due to the long standing effects of diabetes on the microvasculature (glomerulus) of the kidney. Features include increased urine protein and declining kidney function.
Severe diabetic nephropathy can lead to kidney failure and end-stage renal disease.
Origin: Gr. Pathos = disease
(27 Sep 1997)
IgA nephropathy <nephrology, pathology> This is a form of glomerulonephritis that results from the deposition of circulating IgA antibody in the kidney tissues.
Inflammation of the glomerulus (glomerulonephritis) is the result. This condition may present as acute glomerulonephritis, chronic glomerulonephritis or rapidly progressive glomerulonephritis.
Berger's is usually detected in an individual with one or two bouts of bloody urine (usually begins during or soon after a respiratory infection) and no other symptoms of renal disease. Only rarely, will Berger's disease permanently affect kidney function and progress to chronic renal failure. This renal disorder more commonly affects males in the 16-40 age group.
Origin: Gr. Pathos = disease
(27 Sep 1997)
IgM nephropathy <nephrology, pathology> Inflammation of the kidney glomerulus (blood filtering portion of the kidney) due to the abnormal deposition of IgM antibody in the mesangium layer of the glomerular capillary. A form of glomerulonephritis that appears to be caused by an abnormal immune response. This disorder generally manifests as nephrotic syndrome.
Symptoms include swelling, dark urine, weight gain, hypertension, anorexia and bloody urine.
Acronym: MPGN
(05 Jan 1998)
Armanni-Ebstein change Glycogen vacuolization of the loops of Henle, seen in diabetics before the introduction of insulin.
Synonym: Armanni-Ebstein change.
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • nephropathy
    (º´¸®)½ÅÀåÇØ;½ÅÁß;½ÅÀ庴
  • minimal
    ±Ø¼ÒÀÇ; ÃÖÀúÀÇ
  • minimal
    ÃÖ¼ÒÇâ(¼ö)ÀÇ;±Ø¼ÒÀÇ
  • minimal art
    ¹Ì´Ï¸Ö ¾ÆÆ®;ÃÖ¼ÒÇÑÀÇ Á¶Çü ¼ö´ÜÀ¸·Î Á¦ÀÛµÈ ±×¸²;Á¶°¢
  • minimal brain dysfunction
    ¹Ì¼Ò ³ú±â´É Àå¾Ö (¾Æµ¿ÀÇ ÇнÀ Àå¾ÖÀÇ Çϳª)
  • minimal pair
    ÃÖ¼Ò ´ë¾î(bet¿Í bed ó·³ °°Àº À§Ä¡ÀÇ ÇÑ °¡Áö ¼Ò¸®¸¸ ´Ù¸¥ ÇÑ ½ÖÀÇ ³¹¸»)
  • amount of change
    ¸¹Àº Àܵ·(µ¿Àü)
  • change
    º¯È­,±³È¯,º¯È­ÇÏ´Ù,±³È¯ÇÏ´Ù,Àܵ·,µ¿Àü
  • change hands
    ÁÖÀÎÀÌ ¹Ù²î´Ù
  • change
    ¹Ù²Ù´Ù;º¯È­½ÃŰ´Ù;º¯°æÇÏ´Ù;°íÄ¡´Ù;(¿ÊÀ»)...À¸·Î °¥¾Æ ÀÔ´Ù;(ħ´ëÀÇ)½ÃÆ®¸¦ °¥´Ù;(¾î¸°¾ÆÀÌÀÇ)±âÀú±Í¸¦ °¥´Ù;ȯÀüÇÏ´Ù;Àܵ·À¸·Î ¹Ù²Ù´Ù;(¼öÇ¥.¾îÀ½.ȯÀ»)Çö±ÝÀ¸·Î ¹Ù²Ù´Ù;±³È¯ÇÏ´Ù;(Àå¼Ò.ÀÔÀåµîÀ»)¹Ù²Ù´Ù;(Å»°ÍÀ»)°¥¾ÆÅ¸´Ù;¹Ù²ãŸ´Ù;º¯ÇÏ´Ù;¹Ù²î´Ù;º¯È­ÇÏ´Ù;(´Þ.Á¶¼öµîÀÌ)
  • change gear
    (ÀÚµ¿Â÷.±â°èÀÇ)º¯¼Ó±â ÀåÄ¡
  • change machine
    Àܵ· ±³È¯±â
  • change ringing
    (±³È¸ µîÀÇ)ÀüÁ¶ ¸íÁ¾(¹ý)(Á¾À» ¿©·¯°¡Áö À½»ö,ƯÈ÷ 4ºÐÀ½°è·Î ¿ï¸®±â)
  • change wheel
    Àüȯ Åé´Ï¹ÙÄû 
  • change-down
    (ÀÚµ¿Â÷µîÀÇ ±â¾î¸¦)Àú¼ÓÀ¸·Î ¹Ù²Ù±â
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á